169 related articles for article (PubMed ID: 14619628)
1. The adverse effects of corticosteroids in central serous chorioretinopathy.
De Nijs E; Brabant P; De Laey JJ
Bull Soc Belge Ophtalmol; 2003; (289):35-41. PubMed ID: 14619628
[TBL] [Abstract][Full Text] [Related]
2. Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.
Kleinberger AJ; Patel C; Lieberman RM; Malkin BD
Laryngoscope; 2011 Sep; 121(9):2034-7. PubMed ID: 22024860
[TBL] [Abstract][Full Text] [Related]
3. [Central serous chorioretinopathy (CSC) and corticosteroids].
Stoffelns BM; Kramann C; Schoepfer K
Klin Monbl Augenheilkd; 2008 May; 225(5):370-5. PubMed ID: 18454375
[TBL] [Abstract][Full Text] [Related]
4. Endocrine abnormalities in patients with central serous chorioretinopathy.
Haimovici R; Rumelt S; Melby J
Ophthalmology; 2003 Apr; 110(4):698-703. PubMed ID: 12689888
[TBL] [Abstract][Full Text] [Related]
5. Involvement of corticosteroids and catecholamines in the pathogenesis of central serous chorioretinopathy: a rationale for new treatment strategies.
Jampol LM; Weinreb R; Yannuzzi L
Ophthalmology; 2002 Oct; 109(10):1765-6. PubMed ID: 12359592
[No Abstract] [Full Text] [Related]
6. An unusual case of central serous chorioretinopathy in a patient with acute retinal necrosis.
Stuebiger N; Biester S; Deuter CM; Zierhut M
Ocul Immunol Inflamm; 2008; 16(3):109-11. PubMed ID: 18569799
[TBL] [Abstract][Full Text] [Related]
7. Central serous chorioretinopathy, corticosteroids, and uveitis.
Khairallah M; Kahloun R; Tugal-Tutkun I
Ocul Immunol Inflamm; 2012 Apr; 20(2):76-85. PubMed ID: 22409559
[TBL] [Abstract][Full Text] [Related]
8. Central serous chorioretinopathy as a complication of postcardiac transplant corticosteroid therapy.
Singh AD; Demirci H; Shields CL; Shields JA
Eye (Lond); 2003 May; 17(4):522-4. PubMed ID: 12802354
[No Abstract] [Full Text] [Related]
9. Central serous chorioretinopathy.
Marcuson J; Riley T
Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
[TBL] [Abstract][Full Text] [Related]
10. [Wavelength selection in management of central serous chorioretinopathy].
Shang Q; Liu C; Wei S; Shi F; Yang A
Zhonghua Yan Ke Za Zhi; 1999 Nov; 35(6):413-5. PubMed ID: 11835848
[TBL] [Abstract][Full Text] [Related]
11. Fibrotic scar formation in central serous chorioretinopathy developed during systemic treatment with corticosteroids.
Hooymans JM
Graefes Arch Clin Exp Ophthalmol; 1998 Nov; 236(11):876-9. PubMed ID: 9825265
[TBL] [Abstract][Full Text] [Related]
12. The potential role of testosterone in central serous chorioretinopathy.
Grieshaber MC; Staub JJ; Flammer J
Br J Ophthalmol; 2007 Jan; 91(1):118-9. PubMed ID: 17179128
[No Abstract] [Full Text] [Related]
13. Central serous chorioretinopathy associated with testosterone therapy.
Ahad MA; Chua CN; Evans NM
Eye (Lond); 2006 Apr; 20(4):503-5. PubMed ID: 15846380
[No Abstract] [Full Text] [Related]
14. Central serous chorioretinopathy in women.
Quillen DA; Gass DM; Brod RD; Gardner TW; Blankenship GW; Gottlieb JL
Ophthalmology; 1996 Jan; 103(1):72-9. PubMed ID: 8628563
[TBL] [Abstract][Full Text] [Related]
15. [Central serous chorioretinopathy induced by corticosteroids].
Song E; Wakakura M; Ishikawa S
Nippon Ganka Gakkai Zasshi; 1997 Mar; 101(3):257-64. PubMed ID: 9086747
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for posterior cystoid retinal degeneration in central serous chorioretinopathy.
Piccolino FC; De La Longrais RR; Manea M; Cicinelli S; Ravera G
Retina; 2008 Oct; 28(8):1146-50. PubMed ID: 18779722
[TBL] [Abstract][Full Text] [Related]
17. Central serous chorioretinopathy associated with topical corticosteroids in a patient with psoriasis.
Ezra N; Taban M; Behroozan D
J Drugs Dermatol; 2011 Aug; 10(8):918-21. PubMed ID: 21818516
[TBL] [Abstract][Full Text] [Related]
18. An ophthalmological complication: central serous chorioretinopathy in a renal transplant recipient.
Oliaei F; Rasoulinejad A; Seifi B
Transplant Proc; 2007 May; 39(4):1134-5. PubMed ID: 17524913
[TBL] [Abstract][Full Text] [Related]
19. Sympathetic-parasympathetic activity and reactivity in central serous chorioretinopathy: a case-control study.
Tewari HK; Gadia R; Kumar D; Venkatesh P; Garg SP
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3474-8. PubMed ID: 16877418
[TBL] [Abstract][Full Text] [Related]
20. Visual loss due to central serous chorioretinopathy during corticosteroid treatment for giant cell arteritis.
Bevis T; Ratnakaram R; Smith MF; Bhatti MT
Clin Exp Ophthalmol; 2005 Aug; 33(4):437-9. PubMed ID: 16033370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
